Improving Hypertension Medication Adherence for Older Adults
This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that can be used to take medications and manage blood pressure. Both groups will complete a mid-assessment at 3-months and a post-assessment at 6-months.
Conditions:
🦠 Aging 🦠 Medication Adherence 🦠 Hypertension
🗓️ Study Start (Actual) 2 November 2022
🗓️ Primary Completion (Estimated) 31 December 2025
✅ Study Completion (Estimated) 31 December 2025
👥 Enrollment (Estimated) 224
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Tucson, Arizona, United States
📍 Champaign, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * age 65 years or older
    • * self-manage at least one hypertension medication
    • * able to read and speak English
    • * willing to participate in the study for six months
    • * currently have and use an Apple iPhone
    • * have hypertension medication adherence ≤ 90% in the last 2 weeks of the 4-week baseline monitoring period using an AARDEX MEMS® cap

    Exclusion Criteria:

    • * have inadequate visual acuity (worse than 20/50 corrected near vision on Snellen test)
    • * experience severe depression (\> 11 on Geriatric Depression Scale Short Form, GDS-15)
    • * are at risk for cognitive impairment (\< 23 on Montreal Cognitive Assessment, MoCA)
    • * been instructed by their healthcare provider to withhold their blood pressure medication
Ages Eligible for Study: 65 Years to N/A (OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 25 October 2022
  • First Submitted that Met QC Criteria 4 November 2022
  • First Posted 9 November 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 3 May 2024
  • Last Update Posted 6 May 2024
  • Last Verified May 2024